HealthMap

Vanadyl Sulfate and Hepatic Gluconeogenesis in Trials

• Research findings: Clinical and animal trials involving vanadyl sulfate have demonstrated its ability to mimic insulin action and significantly impact glucose metabolism.
• Suppression of gluconeogenesis: Studies indicate that oral administration of vanadyl sulfate helps lower hepatic glucose production (gluconeogenesis) primarily by suppressing key regulatory enzymes in the liver.
• Insulin-sensitizing effects: Rather than increasing insulin secretion, vanadium compounds often work by improving insulin sensitivity at the cellular level and inhibiting glycogenolysis and gluconeogenesis pathways in the liver.
• Biochemical mechanism: The trace mineral acts as a protein tyrosine phosphatase inhibitor, which enhances insulin receptor signaling and subsequently reduces fasting blood glucose levels by curbing excess hepatic glucose output.